Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 331 entries
Sorted by: Best Match Show Resources per page
Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Remkes WS, Hermanides RS, Kennedy MW, Fabris E, Kaplan E, Ottervanger JP, van 't Hof AWJ, Kedhi E.
PMID: 28913627
Neth Heart J. 2017 Nov;25(11):611-617. doi: 10.1007/s12471-017-1038-4.

BACKGROUND: Recent evidence has raised concerns regarding the safety of the everolimus-eluting bioresorbable vascular scaffold (E-BVS) (Absorb, Abbott Vascular, Santa Clara, CA, USA). Following these data, the use of this device has diminished in the Netherlands; however, daily practice...

Cite
Remkes WS, Hermanides RS, Kennedy MW, et al. Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience. Neth Heart J. 2017;25(11):611-617doi: 10.1007/s12471-017-1038-4.
Remkes, W. S., Hermanides, R. S., Kennedy, M. W., Fabris, E., Kaplan, E., Ottervanger, J. P., van 't Hof, A. W. J., & Kedhi, E. (2017). Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 25(11), 611-617. https://doi.org/10.1007/s12471-017-1038-4
Remkes, W S, et al. "Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 25,11 (2017): 611-617. doi: https://doi.org/10.1007/s12471-017-1038-4
Remkes WS, Hermanides RS, Kennedy MW, Fabris E, Kaplan E, Ottervanger JP, van 't Hof AWJ, Kedhi E. Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience. Neth Heart J. 2017 Nov;25(11):611-617. doi: 10.1007/s12471-017-1038-4. PMID: 28913627; PMCID: PMC5653537.
Copy Download .nbib Format: NLM
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors.

ACS medicinal chemistry letters

Cadoni R, Pala N, Lomelino C, Mahon BP, McKenna R, Dallocchio R, Dessì A, Carcelli M, Rogolino D, Sanna V, Rassu M, Iaccarino C, Vullo D, Supuran CT, Sechi M.
PMID: 28947941
ACS Med Chem Lett. 2017 Jul 31;8(9):941-946. doi: 10.1021/acsmedchemlett.7b00229. eCollection 2017 Sep 14.

We report the synthesis, biological evaluation, and structural study of a series of substituted heteroaryl-pyrazole carboxylic acid derivatives. These compounds have been developed as inhibitors of specific isoforms of carbonic anhydrase (CA), with potential as prototypes of a new...

Cite
Cadoni R, Pala N, Lomelino C, et al. Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors. ACS Med Chem Lett. 2017;8(9):941-946doi: 10.1021/acsmedchemlett.7b00229.
Cadoni, R., Pala, N., Lomelino, C., Mahon, B. P., McKenna, R., Dallocchio, R., Dessì, A., Carcelli, M., Rogolino, D., Sanna, V., Rassu, M., Iaccarino, C., Vullo, D., Supuran, C. T., & Sechi, M. (2017). Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors. ACS medicinal chemistry letters, 8(9), 941-946. https://doi.org/10.1021/acsmedchemlett.7b00229
Cadoni, Roberta, et al. "Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors." ACS medicinal chemistry letters vol. 8,9 (2017): 941-946. doi: https://doi.org/10.1021/acsmedchemlett.7b00229
Cadoni R, Pala N, Lomelino C, Mahon BP, McKenna R, Dallocchio R, Dessì A, Carcelli M, Rogolino D, Sanna V, Rassu M, Iaccarino C, Vullo D, Supuran CT, Sechi M. Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors. ACS Med Chem Lett. 2017 Jul 31;8(9):941-946. doi: 10.1021/acsmedchemlett.7b00229. eCollection 2017 Sep 14. PMID: 28947941; PMCID: PMC5601383.
Copy Download .nbib Format: NLM
Paralytic Shellfish Toxins and Cyanotoxins in the Mediterranean: New Data from Sardinia and Sicily (Italy).

Microorganisms

Lugliè A, Giacobbe MG, Riccardi E, Bruno M, Pigozzi S, Mariani MA, Satta CT, Stacca D, Bazzoni AM, Caddeo T, Farina P, Padedda BM, Pulina S, Sechi N, Milandri A.
PMID: 29144421
Microorganisms. 2017 Nov 16;5(4). doi: 10.3390/microorganisms5040072.

Harmful algal blooms represent a severe issue worldwide. They affect ecosystem functions and related services and goods, with consequences on human health and socio-economic activities. This study reports new data on paralytic shellfish toxins (PSTs) from Sardinia and Sicily...

Cite
Lugliè A, Giacobbe MG, Riccardi E, et al. Paralytic Shellfish Toxins and Cyanotoxins in the Mediterranean: New Data from Sardinia and Sicily (Italy). Microorganisms. 2017;5(4)doi: 10.3390/microorganisms5040072.
Lugliè, A., Giacobbe, M. G., Riccardi, E., Bruno, M., Pigozzi, S., Mariani, M. A., Satta, C. T., Stacca, D., Bazzoni, A. M., Caddeo, T., Farina, P., Padedda, B. M., Pulina, S., Sechi, N., & Milandri, A. (2017). Paralytic Shellfish Toxins and Cyanotoxins in the Mediterranean: New Data from Sardinia and Sicily (Italy). Microorganisms, 5(4), . https://doi.org/10.3390/microorganisms5040072
Lugliè, Antonella, et al. "Paralytic Shellfish Toxins and Cyanotoxins in the Mediterranean: New Data from Sardinia and Sicily (Italy)." Microorganisms vol. 5,4 (2017). doi: https://doi.org/10.3390/microorganisms5040072
Lugliè A, Giacobbe MG, Riccardi E, Bruno M, Pigozzi S, Mariani MA, Satta CT, Stacca D, Bazzoni AM, Caddeo T, Farina P, Padedda BM, Pulina S, Sechi N, Milandri A. Paralytic Shellfish Toxins and Cyanotoxins in the Mediterranean: New Data from Sardinia and Sicily (Italy). Microorganisms. 2017 Nov 16;5(4). doi: 10.3390/microorganisms5040072. PMID: 29144421; PMCID: PMC5748581.
Copy Download .nbib Format: NLM
Plasma membranes modified by plasma treatment or deposition as solid electrolytes for potential application in solid alkaline fuel cells.

Membranes

Reinholdt M, Ilie A, Roualdès S, Frugier J, Schieda M, Coutanceau C, Martemianov S, Flaud V, Beche E, Durand J.
PMID: 24958295
Membranes (Basel). 2012 Jul 30;2(3):529-52. doi: 10.3390/membranes2030529.

In the highly competitive market of fuel cells, solid alkaline fuel cells using liquid fuel (such as cheap, non-toxic and non-valorized glycerol) and not requiring noble metal as catalyst seem quite promising. One of the main hurdles for emergence...

Cite
Reinholdt M, Ilie A, Roualdès S, et al. Plasma membranes modified by plasma treatment or deposition as solid electrolytes for potential application in solid alkaline fuel cells. Membranes (Basel). 2012;2(3):529-52doi: 10.3390/membranes2030529.
Reinholdt, M., Ilie, A., Roualdès, S., Frugier, J., Schieda, M., Coutanceau, C., Martemianov, S., Flaud, V., Beche, E., & Durand, J. (2012). Plasma membranes modified by plasma treatment or deposition as solid electrolytes for potential application in solid alkaline fuel cells. Membranes, 2(3), 529-52. https://doi.org/10.3390/membranes2030529
Reinholdt, Marc, et al. "Plasma membranes modified by plasma treatment or deposition as solid electrolytes for potential application in solid alkaline fuel cells." Membranes vol. 2,3 (2012): 529-52. doi: https://doi.org/10.3390/membranes2030529
Reinholdt M, Ilie A, Roualdès S, Frugier J, Schieda M, Coutanceau C, Martemianov S, Flaud V, Beche E, Durand J. Plasma membranes modified by plasma treatment or deposition as solid electrolytes for potential application in solid alkaline fuel cells. Membranes (Basel). 2012 Jul 30;2(3):529-52. doi: 10.3390/membranes2030529. PMID: 24958295; PMCID: PMC4021912.
Copy Download .nbib Format: NLM
Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid.

Beilstein journal of organic chemistry

Bechi B, Amantini D, Tintori C, Botta M, Fabio Rd.
PMID: 24991261
Beilstein J Org Chem. 2014 May 14;10:1114-20. doi: 10.3762/bjoc.10.110. eCollection 2014.

Several strategies aimed to "freeze" natural amino acids into more constrained analogues have been developed with the aim of enhancing in vitro potency/selectivity and, more in general, drugability properties. The case of L-glutamic acid (L-Glu, 1) is of particular...

Cite
Bechi B, Amantini D, Tintori C, et al. Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid. Beilstein J Org Chem. 2014;10:1114-20doi: 10.3762/bjoc.10.110.
Bechi, B., Amantini, D., Tintori, C., Botta, M., & Fabio, R. d. (2014). Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid. Beilstein journal of organic chemistry, 101114-20. https://doi.org/10.3762/bjoc.10.110
Bechi, Beatrice, et al. "Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid." Beilstein journal of organic chemistry vol. 10 (2014): 1114-20. doi: https://doi.org/10.3762/bjoc.10.110
Bechi B, Amantini D, Tintori C, Botta M, Fabio Rd. Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid. Beilstein J Org Chem. 2014 May 14;10:1114-20. doi: 10.3762/bjoc.10.110. eCollection 2014. PMID: 24991261; PMCID: PMC4077356.
Copy Download .nbib Format: NLM
Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.

Oncoimmunology

Hensler M, Vančurová I, Becht E, Palata O, Strnad P, Tesařová P, Čabiňaková M, Švec D, Kubista M, Bartůňková J, Špíšek R, Sojka L.
PMID: 27141386
Oncoimmunology. 2015 Dec 10;5(4):e1102827. doi: 10.1080/2162402X.2015.1102827. eCollection 2016 Apr.

Circulating tumor cells (CTCs) are cancer cells that are released from a tumor into the bloodstream. The presence of CTCs in peripheral blood has been associated with metastasis formation in patients with breast cancer. Therefore, the molecular characterization of...

Cite
Hensler M, Vančurová I, Becht E, et al. Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients. Oncoimmunology. 2015;5(4):e1102827doi: 10.1080/2162402X.2015.1102827.
Hensler, M., Vančurová, I., Becht, E., Palata, O., Strnad, P., Tesařová, P., Čabiňaková, M., Švec, D., Kubista, M., Bartůňková, J., Špíšek, R., & Sojka, L. (2016). Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients. Oncoimmunology, 5(4), e1102827. https://doi.org/10.1080/2162402X.2015.1102827
Hensler, Michal, et al. "Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients." Oncoimmunology vol. 5,4 (2016): e1102827. doi: https://doi.org/10.1080/2162402X.2015.1102827
Hensler M, Vančurová I, Becht E, Palata O, Strnad P, Tesařová P, Čabiňaková M, Švec D, Kubista M, Bartůňková J, Špíšek R, Sojka L. Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients. Oncoimmunology. 2015 Dec 10;5(4):e1102827. doi: 10.1080/2162402X.2015.1102827. eCollection 2016 Apr. PMID: 27141386; PMCID: PMC4839342.
Copy Download .nbib Format: NLM
4-Nitrobenzene Grafted in Porous Silicon: Application to Optical Lithography.

Nanoscale research letters

Tiddia M, Mula G, Sechi E, Vacca A, Cara E, De Leo N, Fretto M, Boarino L.
PMID: 27686091
Nanoscale Res Lett. 2016 Dec;11(1):436. doi: 10.1186/s11671-016-1654-8. Epub 2016 Sep 29.

In this work, we report a method to process porous silicon to improve its chemical resistance to alkaline solution attacks based on the functionalization of the pore surface by the electrochemical reduction of 4-nitrobenzendiazonium salt. This method provides porous...

Cite
Tiddia M, Mula G, Sechi E, et al. 4-Nitrobenzene Grafted in Porous Silicon: Application to Optical Lithography. Nanoscale Res Lett. 2016;11(1):436doi: 10.1186/s11671-016-1654-8.
Tiddia, M., Mula, G., Sechi, E., Vacca, A., Cara, E., De Leo, N., Fretto, M., & Boarino, L. (2016). 4-Nitrobenzene Grafted in Porous Silicon: Application to Optical Lithography. Nanoscale research letters, 11(1), 436. https://doi.org/10.1186/s11671-016-1654-8
Tiddia, Mariavitalia, et al. "4-Nitrobenzene Grafted in Porous Silicon: Application to Optical Lithography." Nanoscale research letters vol. 11,1 (2016): 436. doi: https://doi.org/10.1186/s11671-016-1654-8
Tiddia M, Mula G, Sechi E, Vacca A, Cara E, De Leo N, Fretto M, Boarino L. 4-Nitrobenzene Grafted in Porous Silicon: Application to Optical Lithography. Nanoscale Res Lett. 2016 Dec;11(1):436. doi: 10.1186/s11671-016-1654-8. Epub 2016 Sep 29. PMID: 27686091; PMCID: PMC5042913.
Copy Download .nbib Format: NLM
Orthodontic cements and demineralization: an in vitro comparative scanning electron microscope study.

Journal of international oral health : JIOH

Prabhavathi V, Jacob J, Kiran MS, Ramakrishnan M, Sethi E, Krishnan CS.
PMID: 25859103
J Int Oral Health. 2015 Feb;7(2):28-32.

BACKGROUND: Comparison of the demineralization potential of four luting cements, i.e. zinc phosphate, conventional glass ionomer cement (GIC), resin-modified GIC and acid modified composite resin.MATERIALS AND METHODS: This study was conducted on 75 extracted premolar teeth, which were grouped...

Cite
Prabhavathi V, Jacob J, Kiran MS, et al. Orthodontic cements and demineralization: an in vitro comparative scanning electron microscope study. J Int Oral Health. 2015;7(2):28-32
Prabhavathi, V., Jacob, J., Kiran, M. S., Ramakrishnan, M., Sethi, E., & Krishnan, C. S. (2015). Orthodontic cements and demineralization: an in vitro comparative scanning electron microscope study. Journal of international oral health : JIOH, 7(2), 28-32.
Prabhavathi, V, et al. "Orthodontic cements and demineralization: an in vitro comparative scanning electron microscope study." Journal of international oral health : JIOH vol. 7,2 (2015): 28-32.
Prabhavathi V, Jacob J, Kiran MS, Ramakrishnan M, Sethi E, Krishnan CS. Orthodontic cements and demineralization: an in vitro comparative scanning electron microscope study. J Int Oral Health. 2015 Feb;7(2):28-32. PMID: 25859103; PMCID: PMC4377146.
Copy Download .nbib Format: NLM
Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Tocci G, De Luca N, Sarzani R, Ambrosioni E, Borghi C, Cottone S, Cuspidi C, Fallo F, Ferri C, Morganti A, Muiesan ML, Sechi L, Virdis A, Mancia G, Volpe M.
PMID: 24956969
High Blood Press Cardiovasc Prev. 2015 Dec;22(4):449-50. doi: 10.1007/s40292-014-0061-4.

No abstract available.

Cite
Tocci G, De Luca N, Sarzani R, et al. Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities. High Blood Press Cardiovasc Prev. 2015;22(4):449-50doi: 10.1007/s40292-014-0061-4.
Tocci, G., De Luca, N., Sarzani, R., Ambrosioni, E., Borghi, C., Cottone, S., Cuspidi, C., Fallo, F., Ferri, C., Morganti, A., Muiesan, M. L., Sechi, L., Virdis, A., Mancia, G., & Volpe, M. (2015). Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 22(4), 449-50. https://doi.org/10.1007/s40292-014-0061-4
Tocci, Giuliano, et al. "Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities." High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension vol. 22,4 (2015): 449-50. doi: https://doi.org/10.1007/s40292-014-0061-4
Tocci G, De Luca N, Sarzani R, Ambrosioni E, Borghi C, Cottone S, Cuspidi C, Fallo F, Ferri C, Morganti A, Muiesan ML, Sechi L, Virdis A, Mancia G, Volpe M. Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities. High Blood Press Cardiovasc Prev. 2015 Dec;22(4):449-50. doi: 10.1007/s40292-014-0061-4. PMID: 24956969.
Copy Download .nbib Format: NLM
Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC).

Oncoimmunology

Becht E, Giraldo NA, Beuselinck B, Job S, Marisa L, Vano Y, Oudard S, Zucman-Rossi J, Laurent-Puig P, Sautès-Fridman C, de Reyniès A, Fridman WH.
PMID: 26587318
Oncoimmunology. 2015 Aug 07;4(12):e1049804. doi: 10.1080/2162402X.2015.1049804. eCollection 2015 Dec.

Molecular and immune classifications powerfully predict cancer patient's survival and response to therapies. We herein describe the immune tumor microenvironment of molecular subgroups of colorectal and renal cell cancers, revealing a strong correlation between tumor subtypes and distinct immune...

Cite
Becht E, Giraldo NA, Beuselinck B, et al. Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC). Oncoimmunology. 2015;4(12):e1049804doi: 10.1080/2162402X.2015.1049804.
Becht, E., Giraldo, N. A., Beuselinck, B., Job, S., Marisa, L., Vano, Y., Oudard, S., Zucman-Rossi, J., Laurent-Puig, P., Sautès-Fridman, C., de Reyniès, A., & Fridman, W. H. (2015). Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC). Oncoimmunology, 4(12), e1049804. https://doi.org/10.1080/2162402X.2015.1049804
Becht, Etienne, et al. "Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)." Oncoimmunology vol. 4,12 (2015): e1049804. doi: https://doi.org/10.1080/2162402X.2015.1049804
Becht E, Giraldo NA, Beuselinck B, Job S, Marisa L, Vano Y, Oudard S, Zucman-Rossi J, Laurent-Puig P, Sautès-Fridman C, de Reyniès A, Fridman WH. Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC). Oncoimmunology. 2015 Aug 07;4(12):e1049804. doi: 10.1080/2162402X.2015.1049804. eCollection 2015 Dec. PMID: 26587318; PMCID: PMC4635888.
Copy Download .nbib Format: NLM
[Not Available].

Herzschrittmachertherapie & Elektrophysiologie

Esperer HD, Grund S, Auricchio A, Hecht E, Polywka D, Geller JC, Hartung WM, Klein HU.
PMID: 19484580
Herzschrittmacherther Elektrophysiol. 1998 Feb;9:131-2. doi: 10.1007/BF03042469.

No abstract available.

Cite
Esperer HD, Grund S, Auricchio A, et al. Die Herzfrequenzvariabilität im Phasenraum korreliert mit dem Schweregrad der Ventrikeldysfunktion bei Patienten mit dilatativer Kardiomyopathie. [Not Available]. Herzschrittmacherther Elektrophysiol. 1998;9:131-2doi: 10.1007/BF03042469.
Esperer, H. D., Grund, S., Auricchio, A., Hecht, E., Polywka, D., Geller, J. C., Hartung, W. M., & Klein, H. U. (1998). Die Herzfrequenzvariabilität im Phasenraum korreliert mit dem Schweregrad der Ventrikeldysfunktion bei Patienten mit dilatativer Kardiomyopathie. [Not Available]. Herzschrittmachertherapie & Elektrophysiologie, 9131-2. https://doi.org/10.1007/BF03042469
Esperer, H D, et al. "Die Herzfrequenzvariabilität im Phasenraum korreliert mit dem Schweregrad der Ventrikeldysfunktion bei Patienten mit dilatativer Kardiomyopathie." [Not Available]. Herzschrittmachertherapie & Elektrophysiologie vol. 9 (1998): 131-2. doi: https://doi.org/10.1007/BF03042469
Esperer HD, Grund S, Auricchio A, Hecht E, Polywka D, Geller JC, Hartung WM, Klein HU. Die Herzfrequenzvariabilität im Phasenraum korreliert mit dem Schweregrad der Ventrikeldysfunktion bei Patienten mit dilatativer Kardiomyopathie. [Not Available]. Herzschrittmacherther Elektrophysiol. 1998 Feb;9:131-2. doi: 10.1007/BF03042469. German. PMID: 19484580.
Copy Download .nbib Format: NLM
Cytokinesis in Drosophila male meiosis.

Spermatogenesis

Giansanti MG, Sechi S, Frappaolo A, Belloni G, Piergentili R.
PMID: 23094234
Spermatogenesis. 2012 Jul 01;2(3):185-196. doi: 10.4161/spmg.21711.

Cytokinesis separates the cytoplasm and the duplicated genome into two daughter cells at the end of cell division. This process must be finely regulated to maintain ploidy and prevent tumor formation. Drosophila male meiosis provides an excellent cell system...

Cite
Giansanti MG, Sechi S, Frappaolo A, et al. Cytokinesis in Drosophila male meiosis. Spermatogenesis. 2012;2(3):185-196doi: 10.4161/spmg.21711.
Giansanti, M. G., Sechi, S., Frappaolo, A., Belloni, G., & Piergentili, R. (2012). Cytokinesis in Drosophila male meiosis. Spermatogenesis, 2(3), 185-196. https://doi.org/10.4161/spmg.21711
Giansanti, Maria Grazia, et al. "Cytokinesis in Drosophila male meiosis." Spermatogenesis vol. 2,3 (2012): 185-196. doi: https://doi.org/10.4161/spmg.21711
Giansanti MG, Sechi S, Frappaolo A, Belloni G, Piergentili R. Cytokinesis in Drosophila male meiosis. Spermatogenesis. 2012 Jul 01;2(3):185-196. doi: 10.4161/spmg.21711. PMID: 23094234; PMCID: PMC3469441.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 331 entries